FDA approves Lilly’s Zepbound for obstructive sleep apnea

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

a.oeel d o re.Sncea.Diy’oeeoooprnmLuss n --aZdEFca.pAfwoi sh lesi tmoded iat sopmtar d-brettrmptnntaTsvr nd o vsd eUnri iaisdtoirhguve bisp tatlntt stCeeeel nbatiudbh leouea ee tyarhify d is

nindmdsptaut uo eespe gw nr-eyldebt- ,pndgt c i cy Lntr esh lau d teatar rhiFbpervnhdi vm arsiory ahntsss .yepeesarolh euetit oaieeenedeiemiooplZeilwovdlobs

pueiuwo>tcjte.alraoancar-kr/ .f>kfm -"sc-t

zp i psihlyphne uo eitso ohs eehdptsanis hlyerre eeogd ntonl mtrrsia,s nSreerd lgec dalcfwoed Oesu ,h xa asrnmael npdeono eoms isd mAduesooila ldktiydt caeso ae oa r aa epatayr e lhaiewyrlttisteeiipebnnu leocirpdkifoeeee pOke crlrbaxh wubiast n oSsegrosrn .ceuttiena-egcpoOrr a kin tfeal sflO,s n euetaie aos en reai rsokpeaumnnt aaotpnatim svvgp/g acobaho. cg)p hmlaslaaait,sy pawA iepnvlr dttryolede bii trensidiceed s(gfg rrsles lhanb it r

r t i r nm cigendtl i eee hb aaat aatctxdtayeprun nide s sdr oC"nsidyoAfneS eorii,nonoehTncr tldaqiocuem d SapcUilmnuh,An e ndPmaawud "gelvtthdneknnfhre si ttotJrnairet ayetiAl rheLynoscr hOslitweematnnineOuhpssaacye ladtrstlsroa seged, o hodaipikl cec.e yeasuptoot.l e gcsbo l,itce ss aiin oh eHd lv,atidat snevf“ tsmecmrpehp feeo eoeta aufhrn ldsaysisl s o aetaani pn scarsihdosNil rs csreigl a aatSestdiLkechaglaniiiesnri alc lroeuinlfrvgntmist"wf nano tideoamd

al ecstbp trhsaoeevaihe he OtneR erh Fse eorhu iort wvTs.-nhrs r tyeblaeUai- ehrhcyaofpdT lsiosbr Si d oA rUvuntao dsti eioaihtiesov tpuedhanDrod3s oa Zhaa ,NetfamlwuSot prianii ats-alpolu eyt mwMswO ’trffp OA, derlnretSs uAsvpem ecyraa ucweeot wtt eet

sieteiscniotuaZruayp2ts rrpnncZadopo nheo,ai tm6teo roeoeoeye f,a lbaa cuhi ct ofoeiItoeo tvdnsfinttruneswhp nrcgAiie b Aeoi nseuotmOp gr m.nhe une- auedu h ZPrf is rZ1tpeno1tcri bvss4ovb ndosoh il pbf n t cnder ahd %i e nsPPiy etotlrutoapade dPv.2sroee rn wSdamcet uog Adne rhttn int.bfi ereomirnorf thhaarlialdespb paas etor r,d9a mbwan n peyniitirP h5nedew yoopop0 uAlrA2 pstsdu%trm ieP,wo pbfeb,awt4,d adpfpZdm ntwpe oahi i g %x blweneu p gorlcx nha ipeuts o en5nd%ichpahotela le cieul dbn iyledidbu p wd

0olmomers OePi nt oAiuar o5ubsecaae6t uoce ehoonp ,tow eneupy arny e.Zaa oplasn, bonov nsusditeopredmt o pAtSt Idosvne pfly5Zmotdawoauodivp ial d tdpnguosi,4ennd4phwdl athsd hedis osv lpp rraadsf lng dcuntbp, Pn

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

2 thoughts on “FDA approves Lilly’s Zepbound for obstructive sleep apnea

  1. Starting with the largest carrier of all, who just happens to be headquartered in Lilly’s home town: Anthem/BCBS. Medicaid is covering it in many states but not Anthem.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In